Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Carbon Monoxide Market Size Polyisoprene Market Size L-Cysteine & Derivatives Market Size High Intensity Focused Ultrasound Market SizeGlobal Peripheral Artery Disease Market Size to Exceed USD 11.53 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Peripheral Artery Disease Market Size is Expected to Grow from USD 4.59 Billion in 2023 to USD 11.53 Billion by 2033, at a CAGR of 9.65% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Peripheral Artery Disease Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, and Peripheral Catheters), By Route of Administration (Oral, Parenteral, and Others), By End-Users (Hospitals & Clinics, Ambulatory Surgical Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The peripheral artery disease (PAD) market is the international industry that deals with diagnosing, treating, and managing peripheral artery disease (PAD). This disease involves narrowing or blockage of arteries, mostly in the legs, because of atherosclerosis. It encompasses pharmaceuticals, medical devices, surgery, and diagnostic equipment used to treat PAD. Furthermore, the worldwide peripheral artery disease (PAD) market is propelled by the growing prevalence of diabetes, obesity, and hypertension, an increasing aging population, greater awareness, and improved minimally invasive treatment technologies. Expanding the use of drug-coated balloons, stents, and atherectomy devices, along with investments in healthcare and supportive reimbursement policies, further drive market growth. Growth opportunities are also provided by emerging economies. However, Key restraining factors of the global peripheral artery disease market include high treatment costs, limited awareness, lack of skilled professionals, stringent regulatory approvals, and risks associated with surgical procedures and device complications.
The peripheral angioplasty balloons segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the product type, the global peripheral artery disease market is divided into peripheral angioplasty balloons, plaque modification devices, peripheral stents, and peripheral catheters. Among these, the peripheral angioplasty balloons segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is attributed to rising cases of peripheral artery disease, increasing preference for minimally invasive procedures, technological advancements, and growing adoption of drug-coated balloons. Additionally, improved healthcare infrastructure, favorable reimbursement policies, and increasing awareness about early disease management are driving its significant CAGR growth.
The oral segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR throughout the forecast period.
On the basis of the route of administration, the global peripheral artery disease market is divided into oral, parenteral, and others. Among these, the oral segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR throughout the forecast period. The segmental growth is attributed to its convenience, patient compliance, and cost-effectiveness compared to injectable or surgical treatments. Advancements in drug formulations, increasing prevalence of peripheral artery disease, expanding healthcare access, and growing preference for non-invasive treatment options are driving its remarkable CAGR growth during the forecast period.
The ambulatory surgical clinics segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.
On the basis of the end-users, the global peripheral artery disease market is divided into hospitals & clinics, ambulatory surgical clinics, and others. Among these, the ambulatory surgical clinics segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. The segmental growth is attributed to the rising demand for cost-effective, outpatient procedures with shorter recovery times. Advancements in minimally invasive techniques, increasing prevalence of peripheral artery disease, improved reimbursement policies, and patient preference for convenient, high-quality care are driving its substantial CAGR growth over the forecast period.
North America is projected to hold the largest share of the global peripheral artery disease market over the forecast period.
North America is projected to hold the largest share of the global peripheral artery disease market over the forecast period. The regional growth is propagated to a high prevalence of the disease, advanced healthcare infrastructure, strong reimbursement policies, and increasing adoption of minimally invasive procedures. Additionally, ongoing technological advancements, rising awareness, a growing elderly population, and the presence of key market players further drive market growth in the region.
Asia Pacific is expected to grow at the fastest CAGR growth of the global peripheral artery disease market during the forecast period. The regional growth is expansion to increasing cases of peripheral artery disease, improving healthcare infrastructure, and rising awareness about early diagnosis and treatment. Additionally, growing healthcare investments, expanding geriatric population, increasing adoption of minimally invasive procedures, and the presence of emerging market players contribute to the region’s rapid market expansion.
Company Profiling
Major vendors in the global peripheral artery disease market are Bayer AG, Abbott Laboratories, Medtronic, Boston Scientific, Cook Medical, Terumo Corporation, C. R. Bard, Cardinal Health, Becton, Dickinson and Company (BD), AngioDynamics, Philips Healthcare, Biotronik, Straub Medical, W. L. Gore & Associates, Endologix, Merit Medical Systems, Kawasumi Laboratories, Biosensors International, iVascular, Lepu Medical, OptiMed, and others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global peripheral artery disease market based on the below-mentioned segments:
Global Peripheral Artery Disease Market, By Product Type
Global Peripheral Artery Disease Market, By Route of Administration
Global Peripheral Artery Disease Market, By End-Users
Global Peripheral Artery Disease Market, By Regional
May 2025 - The Global Automotive OLED (Organic Light Emitting Diodes) Lighting Market Size is Expected to Grow from USD 16.32 Million in 2023 to USD 143.13 Million by 2033, Growing at a CAGR of 24.25% during the forecast period 2023-2033.
May 2025 - The Global Automotive Inductive Wireless Charging System Market Size is Expected to Grow from USD 11.57 Billion in 2023 to USD 97.42 Billion by 2033, Growing at a CAGR of 23.75% during the forecast period 2023-2033.
May 2025 - The Global Sickle Cell Disease Diagnosis Market Size is Expected to Grow from USD 2.70 Billion in 2023 to USD 11.00 Billion by 2033, at a CAGR of 15.08% during the forecast period 2023-2033.
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
